| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 141 | Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components | US705458 | 1996-08-29 | US5707670A | 1998-01-13 | Haile Mehansho; Renee Irvine Mellican; Toan Trinh |
| Nutritional iron compositions comprising bioavailable sources of iron selected from ferrous fumarate and ferrous succinate where the iron source is preferably spread on the surface of a lecithin coated edible carrier such as sucrose. These nutritional iron compositions are particularly useful in food and beverage products such as chocolate flavored edible mixes, especially chocolate flavored beverages, that are additionally fortified with other minerals and vitamins, especially multi-mineral and vitamin combinations involving, iodine, vitamin A, vitamin C, riboflavin, and folic acid to avoid developing an undesirable color, off-flavor, astringency, particularly when the edible and/or beverage mix is reconstituted with water or milk. | ||||||
| 142 | Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts | US595716 | 1996-02-02 | US5670344A | 1997-09-23 | Haile Mehansho; Renee Jane Irvine |
| Nutritional chocolate-flavored beverage mixes and other edible mixes that are fortified with highly bioavailable sources of iron such as ferrous fumarate and ferrous sulfate, yet do not develop undesirable gray color when the beverage mix is reconstituted with water or milk, even when the water or milk has been boiled. This problem of gray color development is solved by including edible acids such as citric or malic acid as buffering agents in the beverage mix so that the pH of the reconstituted chocolate beverage is about 6.5 or less. An additional benefit of including these edible buffering acids/salts is that they tend to stabilize the chocolate aroma in the reconstituted beverage. Inclusion of these edible buffering acids/salts in ready-to-serve chocolate-flavored beverages fortified with these highly bioavailable iron sources also prevents the formation of undesirable gray color. | ||||||
| 143 | Food product containing oil-soluble vitamins, digestible fat and indigestible polyol fatty acid polyesters | US459012 | 1989-12-29 | US5248509A | 1993-09-28 | Solke Bruin |
| The present invention pertains to an edible fat-containing product comprising two distinct fat phases (A) and (B); fat phase (A) comprising indigestible polyol fatty acid polyesters and fat phase (B) essentially consisting of digestible fat, wherein fat phase (B) contains an oil-soluble vitamin at a concentration level that is at least twice as high as the concentration level of said vitamin in fat phase (A) and in which fat phase (A) and fat phase (B) are separated from each other by a third phase which is essentially impervious to the oil-soluble vitamin.Yet another aspect of the invention is a process for the preparation of an edible fat-containing product, comprising combining a first fat containing fraction of which the fat essentially consists of digestible fat and which first fraction contains an oil-soluble vitamin, with a second fraction containing indigestible polyol fatty acid polyesters, wherein the concentration level of the oil-soluble vitamin in the digestible fat of the first fraction is at least twice as high as in the polyol fatty acid polyesters of the second fraction, and subjecting the combined fractions to such mild processing conditions that the final product comprises the fat of the first and the fat of the second fraction in the form of two distinct fat phases. | ||||||
| 144 | Chewing gum designed to prevent tooth decay by blending a soluble extract of cacao bean husk | US296998 | 1989-01-13 | US4908212A | 1990-03-13 | Ik B. Kwon; Hyung H. Park; Bong J. An |
| Chewing gum designed to prevent tooth decay, for which a cacao bean husk is extracted by adding water or ethyl alcohol and an extract which is freeze dried after solvent is collected and concentrated by vacuum evaporation is added to the known raw materials of chewing gum in the ratio of 0.1-1.0%. | ||||||
| 145 | Intestinal mineral absorption capacity improver | JP2003380653 | 2003-11-11 | JP4485169B2 | 2010-06-16 | 純二 中村; 久高 小林; 初美 惣野; 大樹 村瀬; 英剛 藤中 |
| The present invention relates to an intestinal mineral absorption capacity improver containing glucose 1-phosphate sodium salt as an effective ingredient. | ||||||
| 146 | Antibacterial agent | JP2001079489 | 2001-03-19 | JP4424871B2 | 2010-03-03 | 忠浩 平本; 亮 竹内; 實 花田; 文孝 野呂瀬 |
| Provided is an antibacterial agent exhibiting an excellent antibacterial activity effect and exerting a mild influence on the environment and humans. The antibacterial agent of the present invention comprises, as an effective component, a mixture of coumarin analogues extracted from a citrus fruit pericarp, particularly a mixture of coumarin analogues obtained from citrus cold press oil. | ||||||
| 147 | 機能性甘味料 | JP2005514105 | 2004-09-22 | JPWO2005027656A1 | 2007-11-15 | 太 松山 |
| コロソリン酸と、スクラーゼ阻害剤及び難消化性デキストリンからなる群より選ばれる少なくとも一つと、をスクロースに添加した甘味料を提供する。 | ||||||
| 148 | Compositions and methods of use, including protein isolate, a protein isolates | JP2003579578 | 2003-03-31 | JP2005521396A | 2005-07-21 | テイッシャー，ピエール; ミカエリアン，ゲアジン |
| タンパク質単離物、特には大豆タンパク質濃縮物の風味の質を改良して吸水率を低減させるための方法が開示される。 本方法は、タンパク質単離物を被覆し、タンパク質分子の風味を遮断し、ならびに水分バリアとして機能するための、多糖を含有する水溶液を用いたタンパク質単離物の表面処理を含む。 処理されたタンパク質単離物は、次に粉末形態に乾燥させられる。 結果として生じたタンパク質単離物の味は口当たりが良く、処理されていないタンパク質単離物に比較して低減された吸水率を有しており、風味を逆戻りさせることなく広範囲の食品に使用できる。 | ||||||
| 149 | Intestinal mineral absorption capacity improver | JP2003380653 | 2003-11-11 | JP2005002091A | 2005-01-06 | FUJINAKA EIGO; NAKAMURA JUNJI; MURASE DAIKI; SOUNO HATSUMI; KOBAYASHI HISATAKA |
| <P>PROBLEM TO BE SOLVED: To obtain an intestinal mineral absorption capacity improver that has high safety. <P>SOLUTION: This intestinal mineral absorption capacity improver contains sodium glucose-1-phosphate as an active ingredient. In a preferred embodiment, the intestinal mineral absorption capacity improver is an oral agent. <P>COPYRIGHT: (C)2005,JPO&NCIPI | ||||||
| 150 | A mixture of fructose and lactose as a low-calorie bulk sweetener with a reduced glycemic index | JP2002576736 | 2002-03-22 | JP2004524040A | 2004-08-12 | ゼーナー、ウォーレン、エル; ゼーナー、リー、アール |
| フルクトースとラクトースとの混合物は、太りすぎのグルコース損傷糖尿病患者である、或いは「追加の糖」からそれらのカロリー分を全く大量に消費しすぎる人々についてカロリー摂取およびグリセミック指数を低下させるのに有用である。 このフルクトース／ラクトース甘味料は、色々な食用調合物中における「追加の糖」の１対１置換物として、毎日の食事の中に、味の質を犠牲にすることなく含められる。 スクロースは、甘味を増すか、またはカロリー値を実質的に変化させずにある種の機能的性質を改善するために、特許請求される甘味料中においてそのフルクトースの全部または一部の置換物として使用することができる。 特許請求される完全熱量性の糖の混合物は、相乗作用的に働いて有効カロリーおよび血糖濃度を下げる。 具体的に言うと、フルクトースはラクトースの正常小腸吸収を強く妨害し、またスクロース吸収を適度に妨害し、一方ラクトースはスクロースと澱粉の両者の正常小腸吸収を妨害する。 吸収されない二糖類およびオリゴ糖は結腸の中に進み、健康によい細菌の増殖を増加させて、この新規な甘味料をプリバイオティックとして有用なものにする。 特許請求される糖混合物を標準食事レベルにおいて摂取するとき、糖不耐性の諸胃腸症状は観察されなかった。 | ||||||
| 151 | Compositions and methods for improving the health of the vascular | JP2001575840 | 2001-04-10 | JP2003530410A | 2003-10-14 | エイ シェヴォー，ケイティ; ジェローム，ラルフ; エイチ シュミッツ，ハロルド; ドンブロスキ，エイミー |
| (57)【要約】 本発明は、少なくとも１つのコレステロール降下剤と共にポリフェノール（例えばプロシアニジンのようなカカオポリフェノール等）を含有する組成物、ならびに粥状動脈硬化症および心血管疾患を治療および予防することを含む血管の健康状態を改善する方法に関する。 | ||||||
| 152 | Chewing gum formulation was overcoat | JP2000609105 | 2000-03-24 | JP2002541123A | 2002-12-03 | ウィリアム ジェイ ウォカス; マイケル ジェイ グリーンバーグ; クリスティーン エル コリヴォー; ロナルド エル リーム |
| (57)【要約】 医薬品又は物質を個体に送達するための方法及び製品が提供される。 この製品は、医薬品又は物質を有するコーティングを含む。 医薬品又は物質は、ガム中心(水溶性部分及び水不溶性基剤部分)を取囲むコーティング内に存在する。 ガムを噛むことにより、医薬品又は物質が製品から放出される。 チューインガムを噛み続けると、口腔内に圧力が生じ、口腔に含まれる口内粘膜を通じて、医薬品又は物質を個体の全身システムへ強制的に移動する。 これは、全身システムへの薬物の吸収に加え、システムにおける薬物の生体利用率を大きく増強する。 | ||||||
| 153 | In nutritional compositions comprising divalent metal salts, the use of emulsifiers to form the bilayers | JP51189498 | 1997-08-28 | JP3245180B2 | 2002-01-07 | トゥリン，トアン．; メハンショ，ハイル．; メリカン，レニー，アーバイン． |
| 154 | Drying stable chocolate drink containing iron and vitamin c | JP31048489 | 1989-11-29 | JP2988946B2 | 1999-12-13 | HEIRU MEHANSHOO; MARIA ERENA TSUNIGA SARUDEIERUNA |
| 155 | Improved fungicidal compositions and methods for their manufacture containing the hexahydro-5-Pirimijinamin compound and thymol | JP32160589 | 1989-12-13 | JPH0678219B2 | 1994-10-05 | SUTEIIBUN ESU DEIRUZU; DEBORA EI NUUNAN |
| 156 | Dry and stable chocolate drink containing iron and vitamin c | JP31048489 | 1989-11-29 | JPH03195456A | 1991-08-27 | HEIRU MEHANSHIYOO; MARIA ERENA TSUNIGA SARUDEIERU |
| PURPOSE: To obtain a drink which has a low water content and a low fat content, contains stable iron and vitamin C and has a good taste and excellent storage stability by compounding a milk solid content, flavor, iron source, vitamin C and sweetener at specific ratios. CONSTITUTION: The desired drink having ≤5% water content and ≤5% fat content is obtd. by compounding the milk solid content (more preferably fat free milk solid content) at the ratio of 0 to 25%, the flavor (more preferably cocoa) at 0.05 to 20%, ferrous fumarate, ferrous succinate or iron-sugar complex at 10 to 100% RDA, the vitamin C at 10 to 150% RDA and the sweetener at 0.5 to 85% and mixing the mixture in a dry state. COPYRIGHT: (C)1991,JPO | ||||||
| 157 | Alpha-glycosyl hesperidin, production and use thereof | JP14190289 | 1989-06-03 | JPH037593A | 1991-01-14 | TSUCHIYA HIROMI; MIYAKE TOSHIO |
| PURPOSE: To obtain α-glycosyl hesperidin having excellent water solubility and excellent physiological activity free from toxicity industrially and advantageously by linking ≥ equimolar amount of D-glucose residue to hesperidin by α bond. CONSTITUTION: Hesperidin is dissolved in a solution having pH ≥7.0 so as to make 0.01-10.0w/v% and blended with 0.5-50 times as much α-glucosyl saccharide compound such as dextrin as hesperidin to give a blended solution. Then the blended solution is mixed with a glycosyltransferase derived from Bacillus stearothermophilus and reacted at pH7.5-10.0 at 50-80°C for about 24 hours to give a reaction solution. Then the reaction solution is heated, filtered to remove insoluble substances, the resulting substance is brought into contact with a porous synthetic adsorbent comprising nonionic styrene-divinylbenzene polymer and purified to collect α-glycosyl hesperidin. Then the hesperidin is contained as an active ingredient to give an drug for alleviating sensitivity diseases or cosmetic. COPYRIGHT: (C)1991,JPO&Japio | ||||||
| 158 | Improved antiseptic composition containing hexahydro-5-pyrimidinamine and thymol and its production | JP32160589 | 1989-12-13 | JPH02288825A | 1990-11-28 | SUTEIIBUN ESU DEIRUZU; DEBORA EI NUUNAN |
| PURPOSE: To obtain an oral cavity antiseptic composition that contains a hexahydro-5-pyrimidinamine and thymol in an oral vehicle and can reduce the dose of the hexahydro-5-pyrimidinamine by their synergism with reduced tooth staining and other inconveniences. CONSTITUTION: This oral antiseptic composition comprises a therapeutically effective amount of a synergistic antiseptic composition comprising (A) microbicidal hexahydro-5-pyriminamine, preferably 1,3-bis(ethylhexyl)hexahydro-5- methyl-5-pyridinamine (hexetidine) or its pharmaceutically acceptable salt and (B) thymol. The amounts of the component A and the component B are 0.01-0.3wt.%, particularly 0.1-0.15wt.% and 0.01-0.4wt.%, particularly 0.06-0.08wt.% based on the whole weight of the composition, respectively. This composition may be utilized in a variety of aqueous-based oral antiseptic products such as mouth wash, rinse, oral spray, tooth gel or confectionery products such as candy or chewing gum. COPYRIGHT: (C)1990,JPO | ||||||
| 159 | Caries controlling method and composition | JP20537681 | 1981-12-21 | JPS57131714A | 1982-08-14 | SUTEIIBUN ESU DEIRUSU |
| 160 | COMPOSITIONS AND METHODS OF USE OF A-TYPE PROCYANIDINS | EP05712740.9 | 2005-01-28 | EP1713467B1 | 2012-08-01 | SCHMITZ, Harold, H.; KWIK-URIBE, Catherine, L.; KELM, Mark, A.; HAMMERSTONE, John, F., Jr. |
| The invention relates to compositions, such as pharmaceuticals, foods, food additives, or dietary supplements, containing A-type procyanidins, and methods of use thereof, for prophylactic or therapeutic treatment of a human or a veterinary animal to treat or prevent NO-responsive health conditions, treat hypertension, cardiovascular disease, coronary artery disease and/or vascular circulation disorders, prevent or reduce the risk of heart attack, stroke, congestive heart failure and/or kidney failure, or to improve blood flow, for example renal blood flow. The composition may optionally contain an additional NO modulating agent and/or a cardiovascular-protective or therapeutic agent, or may be administered in combination with such an agent. | ||||||
QQ群二维码
意见反馈
意见反馈